The effect of active movement of the foot on venous blood flow after total hip replacement.
Surgeons often encourage patients to move their feet in an attempt to prevent venous stasis, but there is little evidence that this measure is beneficial. We investigated the effect of active movement of one foot on the venous blood flow four days after total hip replacement. The actual venous outflow at rest was measured with use of venous occlusion strain-gauge plethysmography in thirty-eight patients. The patients were randomly allocated to the control group (eighteen patients) or the exercise group (twenty patients). A baseline measurement was followed by a one-minute period of rest (control group) or of maximum plantar flexion and dorsiflexion of the foot, ankle, and toes at a rate of thirty cycles per minute (exercise group). The venous outflow was measured again at two, seven, twelve, and thirty minutes in both groups. Movement of the foot for one minute produced a significant and sustained increase (p < 0.002) in the venous outflow (mean maximum increase, 22 per cent). The value remained greater than the baseline level for thirty minutes (mean increase, 6.5 per cent) (p < 0.2). The increase was gradual, reaching a maximum twelve minutes after the completion of exercise. Our results confirm the beneficial hemodynamic effects of active movement of the foot in the postoperative period and suggest that patients should move the feet and ankles postoperatively as part of a prophylactic regimen directed at decreasing the risk of venous thrombosis.
McNally
M A
MA
Department of Orthopaedic Surgery, Musgrave Park Hospital, Belfast, Northern Ireland.
Cooke
E A
EA
Mollan
R A
RA
D000368:Aged; D000369:Aged, 80 and over; D015444:Exercise; D005260:Female; D005528:Foot / Q000502:physiology*; D006622:Hip Prosthesis; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D009068:Movement; D015207:Osteoarthritis, Hip / Q000601:surgery; D010991:Plethysmography; D011183:Postoperative Complications / Q000517:prevention & control*; D012039:Regional Blood Flow; D013924:Thrombophlebitis / Q000517:prevention & control*